abs101.txt	purpose		this	study	aimed	to	compare	the	swallowing	function	in	patients	withhuman	papillomavirus-associated	oropharyngeal	squamous	cell	carcinoma	treatedwith	de-intensified	chemoradiation	therapy	(6	weeks		60	gy)	versus	thosereceiving	standard-of-care	chemoradiation	therapy	(7	weeks		70	gy)	methods	and	materials		a	retrospective	review	was	conducted	of	78	patients	withhuman	papillomavirus-associated	oropharyngeal	squamous	cell	carcinoma	withmodified	barium	swallow	studies	pretreatment	and	6	to	8	weeks	posttreatment		theswallowing	function	was	objectively	scored	for	penetration		aspiration		andpharyngeal	residue		forty	patients	received	de-intensified	chemoradiation	therapy(60	gy	image	guided	radiation	therapy	with	weekly	cisplatin	30	mg/m2)	and	38patients	received	standard-of-care	chemoradiation	therapy	(70	gy	image	guidedradiation	therapy	with	chemotherapy	of	the	medical	oncologist's	choosing)	univariate	and	multivariate	analyses	were	performed	to	detect	differences	betweenthe	cohorts	with	regard	to	laryngeal	penetration		aspiration		and	pharyngealresidue		a	multivariate	logistic	regression	was	used	to	determine	the	overalleffect	of	treatment	on	the	swallowing	function		patient-reported	swallowingoutcomes	in	de-intensified	cohort	were	assessed	with	the	european	organisationfor	research	and	treatment	of	cancer	quality	of	life	module	for	head	and	neckcancer	and	the	patient-reported	outcomes	version	of	the	common	terminologycriteria	for	adverse	events	questionnaires	results		patients	treated	with	de-intensified	chemoradiation	therapy	wereassociated	with	a	suggestion	of	lower	risk	of	developing	overall	swallowingdysfunction	(odds	ratio	[or]		0	62		p	=		07)		laryngeal	penetration	(or		0	63	p	=		12)		and	pharyngeal	residue	(or		0	61		p	=		08)		the	mean	pre-	and	2-yearpost-european	organisation	for	research	and	treatment	of	cancer	quality	of	lifescores	pertaining	to	swallowing	(1-4	scale		higher	worse)	in	the	de-intensifiedcohort	were	1	4	and	1	2	for	liquids		1	2	and	1	1	for	purees		1	5	and	1	7	forsolids		1	0	and	1	3	for	choked	when	swallowing		and	9	0	and	10	8	for	compositescore		respectively		the	mean	pre-	and	2-year	post-patient-reported	outcomesversion	of	the	common	terminology	criteria	for	adverse	events	swallowingdifficulty	scores	(1-5	scale		with	higher	scores	being	worse)	were	1	5	and	1	8	respectively	conclusions		compared	with	7	weeks	of	70	gy		6	weeks	of	60	gy	de-intensifiedchemoradiation	therapy	appears	to	better	preserve	the	baseline	swallowingfunction	(per	objective	modified	barium	swallow	assessment)		patients	treatedwith	de-intensified	chemoradiation	therapy	reported	minimal	changes	in	swallowingfunction	
